Display options
Cite
Hagemann C, Anacker J, Ernestus RI, et al. A complete compilation of matrix metalloproteinase expression in human malignant gliomas. World J Clin Oncol. 2012;3(5):67-79doi: 10.5306/wjco.v3.i5.67.
Hagemann, C., Anacker, J., Ernestus, R. I., & Vince, G. H. (2012). A complete compilation of matrix metalloproteinase expression in human malignant gliomas. World journal of clinical oncology, 3(5), 67-79. https://doi.org/10.5306/wjco.v3.i5.67
Hagemann, Carsten, et al. "A complete compilation of matrix metalloproteinase expression in human malignant gliomas." World journal of clinical oncology vol. 3,5 (2012): 67-79. doi: https://doi.org/10.5306/wjco.v3.i5.67
Hagemann C, Anacker J, Ernestus RI, Vince GH. A complete compilation of matrix metalloproteinase expression in human malignant gliomas. World J Clin Oncol. 2012 May 10;3(5):67-79. doi: 10.5306/wjco.v3.i5.67. PMID: 22582165; PMCID: PMC3349915.
Copy Download .nbib Format: NLM
Share it on

World J Clin Oncol. 2012 May 10;3(5):67-79. doi: 10.5306/wjco.v3.i5.67.

A complete compilation of matrix metalloproteinase expression in human malignant gliomas.

World journal of clinical oncology

Carsten Hagemann, Jelena Anacker, Ralf-Ingo Ernestus, Giles H Vince

Affiliations

  1. Carsten Hagemann, Ralf-Ingo Ernestus, Giles H Vince, Department of Neurosurgery, Tumorbiology Laboratory, University of Würzburg, Josef-Schneider-Str. 11, D-97080 Würzburg, Germany.

PMID: 22582165 PMCID: PMC3349915 DOI: 10.5306/wjco.v3.i5.67

Abstract

Glioblastomas are characterized by an aggressive local growth pattern, a marked degree of invasiveness and poor prognosis. Tumor invasiveness is facilitated by the increased activity of proteolytic enzymes which are involved in destruction of the extracellular matrix of the surrounding healthy brain tissue. Elevated levels of matrix metalloproteinases (MMPs) were found in glioblastoma (GBM) cell-lines, as well as in GBM biopsies as compared with low-grade astrocytoma (LGA) and normal brain samples, indicating a role in malignant progression. A careful review of the available literature revealed that both the expression and role of several of the 23 human MMP proteins is controversely discussed and for some there are no data available at all. We therefore screened a panel of 15 LGA and 15 GBM biopsy samples for those MMPs for which there is either no, very limited or even contradictory data available. Hence, this is the first complete compilation of the expression pattern of all 23 human MMPs in astrocytic tumors. This study will support a better understanding of the specific expression patterns and interaction of proteolytic enzymes in malignant human glioma and may provide additional starting points for targeted patient therapy.

Keywords: Astrocytic tumor; Expression pattern; Glioblastoma cell-lines; Glioblastoma multiforme; Matrix metalloproteinase

References

  1. Neuro Oncol. 2008 Jun;10(3):254-64 - PubMed
  2. Genomics. 1998 Aug 15;52(1):101-6 - PubMed
  3. Methods Mol Biol. 2010;650:129-43 - PubMed
  4. Brain Tumor Pathol. 2003;20(2):39-45 - PubMed
  5. Exp Cell Res. 2001 Feb 15;263(2):209-23 - PubMed
  6. Biochem J. 2003 Oct 1;375(Pt 1):191-7 - PubMed
  7. J Neurooncol. 2011 Nov;105(2):375-81 - PubMed
  8. Int J Biochem Cell Biol. 2008;40(6-7):1362-78 - PubMed
  9. Oncol Rep. 2010 Jun;23(6):1553-9 - PubMed
  10. Clin Exp Metastasis. 1996 Jan;14(1):35-42 - PubMed
  11. Brain Tumor Pathol. 2004;21(3):105-12 - PubMed
  12. Crit Rev Ther Drug Carrier Syst. 2010;27(3):187-236 - PubMed
  13. Am J Pathol. 1998 Aug;153(2):429-37 - PubMed
  14. Annu Rev Cell Dev Biol. 2001;17:463-516 - PubMed
  15. Biochim Biophys Acta. 1998 May 27;1403(1):85-96 - PubMed
  16. J Neurooncol. 1998 Jan;36(1):21-9 - PubMed
  17. Clin Exp Metastasis. 1999;17(7):555-66 - PubMed
  18. Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):58-69 - PubMed
  19. Neuro Oncol. 2000 Jul;2(3):145-50 - PubMed
  20. Eur J Pharmacol. 2006 Aug 7;542(1-3):8-15 - PubMed
  21. Anticancer Res. 1996 Jan-Feb;16(1):121-8 - PubMed
  22. Int J Dev Neurosci. 1999 Aug-Oct;17(5-6):437-45 - PubMed
  23. Cancer Res. 1996 Jan 15;56(2):384-92 - PubMed
  24. J Neurooncol. 2010 Jan;96(2):201-9 - PubMed
  25. Int J Cancer. 2002 May 10;99(2):157-66 - PubMed
  26. Cancer Res. 2004 Oct 1;64(19):6892-9 - PubMed
  27. Cent Eur Neurosurg. 2010 Nov;71(4):173-80 - PubMed
  28. Front Biosci. 2003 Jan 01;8:e261-9 - PubMed
  29. Int J Mol Med. 2009 Jan;23(1):17-31 - PubMed
  30. Anticancer Res. 1997 Nov-Dec;17(6B):4107-9 - PubMed
  31. J Mol Med (Berl). 2004 Oct;82(10):656-70 - PubMed
  32. Brain Tumor Pathol. 2003;20(2):65-72 - PubMed
  33. J Biol Chem. 1995 Mar 10;270(10):5331-8 - PubMed
  34. Annu Rev Cell Biol. 1993;9:541-73 - PubMed
  35. Matrix Biol. 2007 Oct;26(8):587-96 - PubMed
  36. J Immunol. 1998 Dec 15;161(12):6664-73 - PubMed
  37. Brain Tumor Pathol. 2001;18(1):7-12 - PubMed
  38. Brain Pathol. 2005 Oct;15(4):327-41 - PubMed
  39. J Biol Chem. 2005 Jun 10;280(23):21882-92 - PubMed
  40. Lancet. 2003 Jan 25;361(9354):323-31 - PubMed
  41. Biochim Biophys Acta. 2010 Jan;1803(1):29-38 - PubMed
  42. Oncogene. 2008 Aug 14;27(35):4830-40 - PubMed
  43. Microsc Res Tech. 2001 Feb 15;52(4):401-10 - PubMed
  44. Int J Dev Biol. 2004;48(5-6):441-9 - PubMed
  45. J Neurooncol. 1998 Nov;40(2):113-22 - PubMed
  46. BMC Res Notes. 2010 Nov 10;3:293 - PubMed
  47. Neuroscience. 2010 Jun 30;168(2):514-22 - PubMed
  48. Int J Cancer. 2007 Sep 15;121(6):1190-6 - PubMed
  49. J Neurooncol. 2004 Nov;70(2):217-28 - PubMed
  50. Crit Rev Eukaryot Gene Expr. 1997;7(1-2):159-78 - PubMed
  51. Biochim Biophys Acta. 2000 Mar 7;1477(1-2):267-83 - PubMed
  52. Cancer Res. 1999 Jun 1;59(11):2570-6 - PubMed
  53. J Biol Chem. 1996 Apr 12;271(15):9135-40 - PubMed
  54. Cancer Res. 2000 Feb 15;60(4):877-82 - PubMed
  55. Clin Exp Metastasis. 1994 Jul;12(4):296-304 - PubMed
  56. APMIS. 1999 Jan;107(1):38-44 - PubMed
  57. Int J Cancer. 2003 Oct 10;106(6):848-55 - PubMed
  58. J Neurosurg. 2001 Jun;94(6):978-84 - PubMed
  59. Br J Cancer. 1999 Apr;79(11-12):1828-35 - PubMed
  60. Cancer Res. 1991 Mar 15;51(6):1713-9 - PubMed
  61. Clin Exp Metastasis. 2000;18(3):245-52 - PubMed
  62. Clin Neurol Neurosurg. 2002 May;104(2):125-31 - PubMed
  63. Matrix Biol. 1998 Mar;16(8):483-96 - PubMed
  64. J Neuropathol Exp Neurol. 1995 Mar;54(2):236-44 - PubMed
  65. Nature. 1997 Sep 4;389(6646):77-81 - PubMed
  66. Nat Genet. 2009 May;41(5):518-20 - PubMed
  67. Acta Neuropathol. 1997 Oct;94(4):303-9 - PubMed
  68. J Clin Invest. 1999 May;103(9):1237-41 - PubMed
  69. Anticancer Res. 2003 Sep-Oct;23(5A):3937-44 - PubMed
  70. Int J Oncol. 2007 Apr;30(4):793-802 - PubMed
  71. J Biol Chem. 1999 Feb 19;274(8):4570-6 - PubMed
  72. Mol Carcinog. 2007 Jun;46(6):446-52 - PubMed
  73. Expert Opin Drug Deliv. 2011 Apr;8(4):415-33 - PubMed
  74. J Korean Med Sci. 2000 Jun;15(3):309-14 - PubMed
  75. Oncol Rep. 2010 Jan;23(1):69-78 - PubMed
  76. J Neurosurg. 2001 Mar;94(3):464-73 - PubMed
  77. Genes Dev. 2000 Sep 1;14(17):2123-33 - PubMed
  78. J Neuroinflammation. 2009 Mar 09;6:8 - PubMed
  79. Acta Neurochir (Wien). 2003 Sep;145(9):825-38 - PubMed
  80. Expert Opin Drug Deliv. 2009 Oct;6(10):1017-32 - PubMed
  81. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5578-82 - PubMed
  82. J Biol Chem. 1991 Jul 25;266(21):14064-71 - PubMed
  83. J Clin Oncol. 2002 Mar 1;20(5):1383-8 - PubMed
  84. Trends Neurosci. 1998 Feb;21(2):75-80 - PubMed
  85. Neurotherapeutics. 2009 Jul;6(3):539-46 - PubMed
  86. Expert Rev Mol Med. 2011 May 13;13:e17 - PubMed
  87. J Clin Oncol. 2000 Mar;18(5):1135-49 - PubMed
  88. Biochem Pharmacol. 2010 May 15;79(10):1483-95 - PubMed
  89. Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15575-80 - PubMed
  90. J Neurooncol. 2001 Jun;53(2):99-106 - PubMed
  91. J Neurooncol. 2001 Jun;53(2):187-202 - PubMed
  92. J Neuropathol Exp Neurol. 2001 Jun;60(6):598-612 - PubMed
  93. Int J Cancer. 2005 Dec 10;117(5):781-5 - PubMed
  94. Invasion Metastasis. 1998-1999;18(5-6):271-84 - PubMed
  95. J Cell Physiol. 2007 Nov;213(2):355-64 - PubMed
  96. J Neurosci. 2003 May 15;23(10):4034-43 - PubMed
  97. J Biol Chem. 1999 Jul 30;274(31):21491-4 - PubMed
  98. J Cell Physiol. 2007 Apr;211(1):19-26 - PubMed
  99. J Biol Chem. 2010 Jun 18;285(25):19647-59 - PubMed
  100. Nat Rev Cancer. 2002 Mar;2(3):161-74 - PubMed
  101. Int J Cancer. 1999 Mar 1;80(5):764-72 - PubMed
  102. Clin Exp Metastasis. 1996 Jan;14(1):12-8 - PubMed
  103. J Neurosurg. 1994 Jul;81(1):69-77 - PubMed
  104. J Neurooncol. 2006 Jul;78(3):295-302 - PubMed
  105. J Cell Physiol. 2010 Nov;225(2):472-81 - PubMed
  106. J Neurosurg. 1995 Aug;83(2):298-307 - PubMed
  107. Nature. 1995 May 18;375(6528):244-7 - PubMed
  108. J Cell Sci. 2005 May 15;118(Pt 10):2325-40 - PubMed
  109. Mol Cancer Res. 2003 Mar;1(5):333-45 - PubMed
  110. FEBS Lett. 2001 Nov 2;507(3):285-7 - PubMed
  111. Cancer Res. 2000 Dec 15;60(24):6851-5 - PubMed
  112. FEBS Lett. 1996 Sep 9;393(1):101-4 - PubMed
  113. Am J Pathol. 1999 Feb;154(2):417-28 - PubMed
  114. Clin Cancer Res. 2002 Sep;8(9):2894-901 - PubMed
  115. Discov Med. 2010 Oct;10(53):293-304 - PubMed
  116. Clin Exp Metastasis. 1996 Oct;14(5):421-33 - PubMed
  117. Neurosurgery. 1993 May;32(5):716-20; discussion 720 - PubMed
  118. Nat Rev Cancer. 2001 Oct;1(1):46-54 - PubMed
  119. Cancer Res. 2008 Apr 15;68(8):2755-63 - PubMed
  120. Nat Rev Cancer. 2002 Sep;2(9):657-72 - PubMed
  121. J Biochem. 1998 Aug;124(2):462-70 - PubMed
  122. Eur J Cell Biol. 1997 Oct;74(2):111-22 - PubMed
  123. Cancer Res. 2002 Feb 1;62(3):675-81 - PubMed
  124. Biochem Biophys Res Commun. 2005 Nov 18;337(2):510-6 - PubMed
  125. J Neurooncol. 2001 Jun;53(2):213-35 - PubMed
  126. Oncogene. 2004 Jun 10;23(27):4681-9 - PubMed
  127. Neurosci Res. 2008 Jan;60(1):40-9 - PubMed
  128. J Neurooncol. 1997 Dec;35(3):249-57 - PubMed
  129. J Neurooncol. 2001 Jun;53(2):177-85 - PubMed
  130. Cancer Res. 2006 Dec 15;66(24):11771-80 - PubMed
  131. Mol Cell Biochem. 2003 Nov;253(1-2):269-85 - PubMed
  132. N Engl J Med. 2005 Mar 10;352(10):987-96 - PubMed
  133. Neuro Oncol. 2004 Jul;6(3):188-99 - PubMed

Publication Types